Insider · CIK 0001463740
Jeff Huber
director
Files at EA (ELECTRONIC ARTS INC.), SMMT (Summit Therapeutics Inc.), UPST (Upstart Holdings, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | EA ELECTRONIC ARTS INC. | MOption exercise Common Stockindirect: By Trust | +168 | $122.91 | $21k | 16,646 | Feb 5, 2025 |
| Feb 3, 2025 | EA ELECTRONIC ARTS INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +168 | $111.61 | $19k | 168 | Feb 5, 2025 |
| Feb 3, 2025 | EA ELECTRONIC ARTS INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -168 | $0.00 | $0 | 0 | Feb 5, 2025 |
| Jan 10, 2025 | UPST Upstart Holdings, Inc. | AGrant or award Common Stock | +542 | $0.00 | $0 | 25,357 | Jan 14, 2025 |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 6, 2025 |
| Nov 1, 2024 | EA ELECTRONIC ARTS INC. | MOption exercise Common Stockindirect: By Trust | +136 | $151.26 | $21k | 16,478 | Nov 4, 2024 |
| Nov 1, 2024 | EA ELECTRONIC ARTS INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +136 | $137.87 | $19k | 136 | Nov 4, 2024 |
| Nov 1, 2024 | EA ELECTRONIC ARTS INC. | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -136 | $0.00 | $0 | 0 | Nov 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.